Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat tablets for gout with hyperuricemia (Phase II, randomized double-blind active-controlled)
CTR20160236Phase 2Active
- Sponsor
- Ningbo Lihua Pharmaceutical
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of febuxostat in gout, hyperuricemia, sponsored by Ningbo Lihua Pharmaceutical. Started Jun 2016; status: active.
02
Drugs
febuxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on CTR20160236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160236.